Barely Significant
← all excerpts

Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types.

Pharmaceuticals (Basel) · 2025 · PMC12655786 · PMID 41305005

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Osteosarcoma, Cervical, and Bone Marrow Cancers In osteosarcoma, the combination of curcumin and methotrexate showed a trend of reduced expression of NF-κB and matrix metalloproteinases, indicating potential synergy for anti-tumor effects [ 78 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.